| Neonatal abstinence syndrome after methadone or buprenorphine exposure HE Jones, K Kaltenbach, SH Heil, SM Stine, MG Coyle, AM Arria, ... New England Journal of Medicine 363 (24), 2320-2331, 2010 | 1065 | 2010 |
| Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. J Armitage, L Bowman, K Wallendszus, R Bulbulia, K Rahimi, R Haynes, ... Lancet (London, England) 376 (9753), 2010 | 533 | 2010 |
| Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome HE Jones, RE Johnson, DR Jasinski, KE O’Grady, CA Chisholm, ... Drug and alcohol dependence 79 (1), 1-10, 2005 | 340 | 2005 |
| Unintended pregnancy in opioid-abusing women SH Heil, HE Jones, A Arria, K Kaltenbach, M Coyle, G Fischer, S Stine, ... Journal of substance abuse treatment 40 (2), 199-202, 2011 | 323 | 2011 |
| Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta‐analysis of safety in the mother, fetus and child BK Zedler, AL Mann, MM Kim, HR Amick, AR Joyce, EL Murrelle, ... Addiction 111 (12), 2115-2128, 2016 | 254 | 2016 |
| Use of buprenorphine in pregnancy: patient management and effects on the neonate RE Johnson, HE Jones, G Fischer Drug and alcohol dependence 70 (2), S87-S101, 2003 | 244 | 2003 |
| Treatment of opioid-dependent pregnant women: clinical and research issues HE Jones, PR Martin, SH Heil, K Kaltenbach, P Selby, MG Coyle, ... Journal of substance abuse treatment 35 (3), 245-259, 2008 | 228 | 2008 |
| Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes HE Jones, KE O'Grady, D Malfi, M Tuten American Journal on Addictions 17 (5), 372-386, 2008 | 218 | 2008 |
| Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance SL Klaman, K Isaacs, A Leopold, J Perpich, S Hayashi, J Vender, ... Journal of addiction medicine 11 (3), 178-190, 2017 | 210 | 2017 |
| Buprenorphine treatment of opioid‐dependent pregnant women: a comprehensive review HE Jones, SH Heil, A Baewert, AM Arria, K Kaltenbach, PR Martin, ... Addiction 107, 5-27, 2012 | 205 | 2012 |
| Methadone and buprenorphine for the management of opioid dependence in pregnancy HE Jones, LP Finnegan, K Kaltenbach Drugs 72, 747-757, 2012 | 178 | 2012 |
| Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure RE Choo, MA Huestis, JR Schroeder, AS Shin, HE Jones Drug and alcohol dependence 75 (3), 253-260, 2004 | 168 | 2004 |
| The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women HE Jones, N Haug, K Silverman, M Stitzer, D Svikis Drug and alcohol dependence 61 (3), 297-306, 2001 | 168 | 2001 |
| Inhalant abuse in pregnancy HE Jones, RL Balster Obstetrics and gynecology clinics of North America 25 (1), 153-167, 1998 | 160 | 1998 |
| Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes RE Johnson, HE Jones, DR Jasinski, DS Svikis, NA Haug, LM Jansson, ... Drug and alcohol dependence 63 (1), 97-103, 2001 | 156 | 2001 |
| Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes K Kaltenbach, KE O’Grady, SH Heil, AL Salisbury, MG Coyle, G Fischer, ... Drug and alcohol dependence 185, 40-49, 2018 | 142 | 2018 |
| Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers HE Jones, K Deppen, ML Hudak, L Leffert, C McClelland, L Sahin, ... American journal of obstetrics and gynecology 210 (4), 302-310, 2014 | 141 | 2014 |
| Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009 GK Welle-Strand, S Skurtveit, HE Jones, H Waal, B Bakstad, L Bjarkø, ... Drug and alcohol dependence 127 (1-3), 200-206, 2013 | 135 | 2013 |
| Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers HE Jones, BE Garrett, RR Griffiths Journal of Pharmacology and Experimental Therapeutics 288 (1), 188-197, 1999 | 133 | 1999 |
| Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication K Kaltenbach, AM Holbrook, MG Coyle, SH Heil, AL Salisbury, SM Stine, ... Addiction 107, 45-52, 2012 | 131 | 2012 |
